Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 3, 2025 • 7:01 PM ET
As of January 3, 2025 • 7:01 PM ET
Date/Time | Source | News Release |
---|---|---|
11/04/2024 10:22 AM EST | SeekingAlpha | CytoDyn Phase 2 study of leronlimab cleared by FDA |
10/30/2024 11:19 AM EDT | Zacks | AutoNation Stock Falls 3.7% Since Q3 Earnings Miss Estimates |
10/30/2024 11:15 AM EDT | Zacks | Penske Q3 Earnings Miss Expectations, Revenues Rise Y/Y |
10/29/2024 09:54 AM EDT | Zacks | Lear Shares Shrink 4% Since Q3 Earnings Beat Expectations |
07/09/2024 09:08 AM EDT | SeekingAlpha | CytoDyn announces settlement with Amarex Clinical |
04/15/2024 07:01 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, April 15th, 2024 |
04/15/2024 05:32 AM EDT | US Earnings Reports | Expected earnings - Cytodyn Inc |
04/08/2024 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, April 8th, 2024 |
04/08/2024 05:33 AM EDT | US Earnings Reports | Expected earnings - Cytodyn Inc |
02/29/2024 10:21 AM EST | SeekingAlpha | FDA lifts clinical hold on CytoDyn drug, stock rallies 22% |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.